Nuvation Bio Inc.

NYSE:NUVB

2.88 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 477.284-462.492-14.792-13.787-19.649-20.64-21.726-20.845-27.203-34.858-21.293-25.134-21.979-19.333-20.402-13.28-11.034-8.599-8.746-0.01-0.005-0.009-0.009
Depreciation & Amortization -0.3020.2440.0580.0550.0550.0560.0560.0490.0560.0480.0460.0430.070.0410.030.0270.0260.0260.0240000
Deferred Income Tax 000-4.665-3.818-2.85700000-2.159000.87600000000
Stock Based Compensation 09.5695.0413.7225.4315.5234.8374.9882.944.7873.5772.82.7492.1531.5661.1250.3480.3890.340000
Change In Working Capital 10.734-6.125-4.609-1.4411.8290.451-0.2990.184-4.3993.689-2.9210.7844.892-0.296-0.587-1.1612.5861.18-0.495-0.001-000
Accounts Receivables 0.3090.272-0.581-0.669-0.238-0.5220.212-0.1350.318-0.1750.546-1.2250.183-0.9820.07700000000
Change In Inventory 000-0.5480.2380.522-0.2120.135-0.3180.1750000000000000
Change In Accounts Payables 2.791-3.0180.227-0.164-0.204-0.3680.806-0.856-9.7333.0555.748-1.1730.636-1.5423.94-1.6662.233-0.7730.240000
Other Working Capital 7.634-3.379-4.255-0.6082.0330.819-1.1051.045.3340.634-8.6691.9574.2561.246-4.5270.5050.3531.953-0.735-0.001-000
Other Non Cash Items -434.69434.2834.1111.087-0.003-0.018-2.198-0.5450.514-0.584-4.3380.1841.120.6053.7870.3520.0360.1680.1590.001-0.0020.0050.005
Operating Cash Flow 53.026-37.324-15.702-15.029-16.155-17.485-19.33-16.169-28.092-26.918-24.929-23.482-13.148-16.83-14.73-12.937-8.038-6.836-8.718-0.009-0.007-0.004-0.004
Investing Activities:
Investments In Property Plant And Equipment 0.0270-0.027-0.013-0.022-0.022-0.012-0.065-0.103-0.195-0.007-0.135-0.029-0.004-0.114-0.027-0.015-0.006-0.097-0-000
Acquisitions Net -12.5212.5200.0140.01-0.03751.9960.0060.007-0.0275.551454.669001.08500000000
Purchases Of Investments 221.939-93.53-128.409-148.738-110.835-206.833-236.967-137.709-119.926-131.003-131.669-254.452-123.175-207.16-24.513-136.056-1.062-4.606-1.5650000
Sales Maturities Of Investments -251.261115.283135.978181.9101.265244.201184.983115.939184.225157.832126.12565.32331.48234.56623.54237.8187.59415.43212.270000
Other Investing Activites 70.93121.7537.542-0-0.010.037-51.996-0.0220.0640.027-5.551-454.669-0.092-0.173-1.085-0.0980.0070.0110.0110.008-0.12300
Investing Cash Flow 29.11634.2737.54233.163-9.59237.346-51.996-21.82964.20326.634-5.551-189.264-91.722-172.598-1.085-98.2656.51710.8210.6080.007-0.12300
Financing Activities:
Debt Repayment -0.713-0.71300000000000000000-0000
Common Stock Issued -2.0562.0350.0210.120.0770.1330.2980.4070.258-3.6024.2640.538624.7990.19000000000
Common Stock Repurchased 00000000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 1.2312.7480.021000000-3.6024.2640.538-0.0320.057624.964132.6350.500-0-0.0020.0730.073
Financing Cash Flow -1.5382.7480.0210.120.0770.1330.2980.4070.258-3.6024.2640.538-0.0320.057624.964132.6350.500-0-0.0020.0730.073
Other Information:
Effect Of Forex Changes On Cash -0.6640.078000000000000000000000
Net Change In Cash 79.94-0.225-8.13918.254-25.6719.994-71.028-37.59136.369-3.886-26.216-212.208-104.902-189.371609.14921.433-1.0213.9841.89-0.002-0.1320.0690.069
Cash At End Of Period 114.22534.28534.5142.64924.39550.06530.071101.099138.69102.321106.207132.423344.631449.533638.90429.7558.3229.3435.3590.0030.0060.1380.069